Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Telehealth and Telemedicine Market (2024 Edition): Analysis by Component, Mode of Delivery, Application, Region, and Country: Market Insights and ...

Peak, one of the telemedicine companies advertising psychedelic therapy via ketamine doses on TikTok, has announced they are "winding down" their controversial membership service. "Since day one, our ...

DELRAY BEACH, Fla., Sept. 28, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Telehealth and Telemedicine Market is ...

San Francisco-based telemedicine provider Doctor On Demand announced today the closure of a $74 million round of Series C financing. The funding round was led by Princeville Global and Goldman Sachs ...

Add Yahoo as a preferred source to see more of our stories on Google. Telehealth is an easy way to connect with medical providers online. There are various telemedicine services offering different ...

In February 2024, DOJ touted 2023 as the year it secured the “highest number of [False Claims Act] settlements and judgments in history” and identified the health care industry as the “leading source” ...

A telemedicine startup that’s developed a virtual doctors’ office kiosk has signed a technology integration deal with wireless communications giant Sprint. For a relatively obscure startup like ...

Telemedicine companies are supposed to facilitate medically necessary services to beneficiaries over the telephone via licensed medical professionals. In reality, however, many of these “telemedicine ...

Last Friday seven companies and four men were charged with involvement in a $1 billion telemedicine fraud scheme, where they allegedly filed false claims for payment and mislead doctors and patients ...

At the time, Teladoc Health was hailed as the ultimate telemedicine darling; its stock price skyrocketed to nearly $300 per share. But the euphoria was relatively short-lived. With its current share ...

Eli Lilly (NYSE:LLY) has filed lawsuits against four telehealth platforms that the pharma giant alleges are selling compounded versions of its blockbuster GLP-1/GIP receptor agonist tirzepatide that ...